Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

PARNAX LAB LTD. - 506128 - Closure of Trading Window

 Dear Sir/Madam, Pursuant to BSE Circulars dated 2nd April, 2019 vide Ref No: LIST/COMP/01/2019-20. Further to our letter dated 29th December, 2021, please note that the Trading Window for dealing in the securities of the Company shall continue to remain closed for all Designated Persons with effect from 01st January, 2022 for the purpose of consideration of Unaudited Financial result for the quarter ended 31st December, 2021. The Trading Window shall open 48 hours after the Unaudited Financial Result for the quarter ended 31st December, 2021 become generally available to the public. The above is for your information and record. Kindly take the same on your record and oblige.
31-12-2021
Bigul

PARNAX LAB LTD. - 506128 - Closure of Trading Window

 Dear Sir/Madam, Pursuant to BSE Circulars dated 2nd April, 2019 vide Ref No: LIST/COMP/01/2019-20 please note that the Trading Window for dealing in the securities of the Company will remain closed for all Designated Persons and insiders with effect from 29th December, 2021 for the purpose of consideration and evaluation of proposal by the board for raising funds by way of issue of warrants convertible into equity shares through preferential issue including determination of issue price as may be permitted under applicable laws, subject to the approval of the shareholders of the Company; The Trading Window shall remain open 48 hours after the dissemination of the outcome of the meeting. The above is for your information and record. Kindly take the same on your record and oblige.
29-12-2021
Bigul

PARNAX LAB LTD. - 506128 - Board Meeting Intimation for Considering And Evaluating Proposals For Raising Funds By Way Of Issue Of Warrants Convertible Into Equity Shares Through Preferential Issue Including Determination Of Issue Price

 PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/01/2022 ,inter alia, to consider and approve 1. proposals for raising funds by way of issue of warrants convertible into equity shares through preferential issue including determination of issue price as may be permitted under applicable laws, subject to the approval of the shareholders of the Company; 2. To confirm the Date, Time, and Notice for convening Extra-Ordinary General Meeting ('EOGM') of the members of the Company; 3. Any other matter, if required with the permission of the chair. Further, the trading window for insiders has been closed from December 29, 2021 and shall continue to remain closed till 48 (Forty-Eight) hours after the dissemination of the outcome meeting. This is for your information and records. Thanking you.
29-12-2021
Bigul

PARNAX LAB LTD. - 506128 - Results-Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2021.

 Kindly find enclosed herewith the following: 1. A Copy of Standalone & Consolidated Un-Audited Financial results with Limited Review Report of the Company for the quarter and half year ended 30th September 2021. The aforesaid information and Financial Results are being made available on the Company''s website at www.naxparlab.com Kindly take on your record and acknowledge receipt of the same.
13-11-2021
Bigul

PARNAX LAB LTD. - 506128 - Board Meeting Outcome for Outcome Of Board Meeting

 Dear Sir, Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Saturday, 13th November, 2021 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Un-Audited Standalone & Consolidated Financial Results as submitted by statutory auditor of the Company for the quarter and half year ended 30th September, 2021. 2. Considered and took note of Limited Review Report for the quarter and half year ended 30th September, 2021. The Meeting was commenced at 5.00 p.m. and concluded at 5.30 p.m. Kindly take the same on your record & Oblige.
13-11-2021
Bigul

Parnax Lab Ltd - 506128 - Board Meeting Intimation for Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2021.

 PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2021 ,inter alia, to consider and approve Standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter and half year ended 30th September, 2021 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director. The approved results will be sent to you after conclusion of Board meeting. Kindly acknowledge the receipt of the same and Oblige
05-11-2021
Bigul

PARNAX LAB LTD. - 506128 - Shareholding for the Period Ended September 30, 2021

 Parnax Lab Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
20-10-2021
Bigul

Parnax Lab Ltd - 506128 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Dear Sir, Pursuant to the provisions of Regulation 74(5) or Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018, Please find enclosed herewith Compliance Certificate received from the Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of our Company for the quarter ended 30th September, 2021. You are requested to take the same on record.
10-10-2021
Bigul

PARNAX LAB LTD. - 506128 - Statement Of Investor Complaints For The Quarter Ended September 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Preet Vijay KukrejaDesignation :- Company Secretary and Compliance Officer
09-10-2021
Bigul

Parnax Lab Ltd - 506128 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Parnax Lab Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
04-10-2021
Next Page
Close

Let's Open Free Demat Account